Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation
- Author
- Eva Schepers (UGent) , Griet Glorieux (UGent) , Laetitia Dou, Claire Cerini, Nathalie Gayrard, Loïc Louvet, Charlotte Maugard, Pierre Preus, Maria Rodriguez-Ortiz, Angel Argiles, Philippe Brunet, Gerald Cohen, Joachim Jankowski, Vera Jankowski, Ziad Massy, Mariano Rodriguez and Raymond Vanholder (UGent)
- Organization
- Keywords
- Atherosclerosis, Chronic kidney disease, Guanidino compounds, SDMA, Uremic toxins, Vascular damage, CHRONIC-RENAL-FAILURE, UREMIC RETENTION SOLUTES, CORONARY-ARTERY-DISEASE, SOLUBLE L-SELECTIN, ASYMMETRICAL DIMETHYLARGININE, DIALYZED PATIENTS, P-CRESOL, HEMODIALYSIS, PLASMA, MORTALITY
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 217.44 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-1268752
- MLA
- Schepers, Eva, et al. “Guanidino Compounds as Cause of Cardiovascular Damage in Chronic Kidney Disease: An in Vitro Evaluation.” BLOOD PURIFICATION, vol. 30, no. 4, 2010, pp. 277–87, doi:10.1159/000320765.
- APA
- Schepers, E., Glorieux, G., Dou, L., Cerini, C., Gayrard, N., Louvet, L., … Vanholder, R. (2010). Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation. BLOOD PURIFICATION, 30(4), 277–287. https://doi.org/10.1159/000320765
- Chicago author-date
- Schepers, Eva, Griet Glorieux, Laetitia Dou, Claire Cerini, Nathalie Gayrard, Loïc Louvet, Charlotte Maugard, et al. 2010. “Guanidino Compounds as Cause of Cardiovascular Damage in Chronic Kidney Disease: An in Vitro Evaluation.” BLOOD PURIFICATION 30 (4): 277–87. https://doi.org/10.1159/000320765.
- Chicago author-date (all authors)
- Schepers, Eva, Griet Glorieux, Laetitia Dou, Claire Cerini, Nathalie Gayrard, Loïc Louvet, Charlotte Maugard, Pierre Preus, Maria Rodriguez-Ortiz, Angel Argiles, Philippe Brunet, Gerald Cohen, Joachim Jankowski, Vera Jankowski, Ziad Massy, Mariano Rodriguez, and Raymond Vanholder. 2010. “Guanidino Compounds as Cause of Cardiovascular Damage in Chronic Kidney Disease: An in Vitro Evaluation.” BLOOD PURIFICATION 30 (4): 277–287. doi:10.1159/000320765.
- Vancouver
- 1.Schepers E, Glorieux G, Dou L, Cerini C, Gayrard N, Louvet L, et al. Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation. BLOOD PURIFICATION. 2010;30(4):277–87.
- IEEE
- [1]E. Schepers et al., “Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation,” BLOOD PURIFICATION, vol. 30, no. 4, pp. 277–287, 2010.
@article{1268752,
author = {{Schepers, Eva and Glorieux, Griet and Dou, Laetitia and Cerini, Claire and Gayrard, Nathalie and Louvet, Loïc and Maugard, Charlotte and Preus, Pierre and Rodriguez-Ortiz, Maria and Argiles, Angel and Brunet, Philippe and Cohen, Gerald and Jankowski, Joachim and Jankowski, Vera and Massy, Ziad and Rodriguez, Mariano and Vanholder, Raymond}},
issn = {{0253-5068}},
journal = {{BLOOD PURIFICATION}},
keywords = {{Atherosclerosis,Chronic kidney disease,Guanidino compounds,SDMA,Uremic toxins,Vascular damage,CHRONIC-RENAL-FAILURE,UREMIC RETENTION SOLUTES,CORONARY-ARTERY-DISEASE,SOLUBLE L-SELECTIN,ASYMMETRICAL DIMETHYLARGININE,DIALYZED PATIENTS,P-CRESOL,HEMODIALYSIS,PLASMA,MORTALITY}},
language = {{eng}},
number = {{4}},
pages = {{277--287}},
title = {{Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation}},
url = {{http://doi.org/10.1159/000320765}},
volume = {{30}},
year = {{2010}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: